How a menu of adherence support strategies facilitated high adherence to HIV prevention products among adolescent girls and young women in sub‐Saharan Africa: a mixed methods analysis
Introduction Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The MTN‐034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine v...
Saved in:
Published in | Journal of the International AIDS Society Vol. 26; no. 11; pp. e26189 - n/a |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
John Wiley & Sons, Inc
01.11.2023
Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Introduction
Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The MTN‐034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine vaginal ring. Understanding how these strategies promoted product use could inform the design of adherence support systems in programmatic settings.
Methods
REACH was a randomized crossover trial evaluating the safety of and adherence to the ring and oral PrEP among 247 HIV‐negative AGYW (ages 16–21) in South Africa, Uganda and Zimbabwe from January 2019 to September 2021 (NCT03593655). Adherence support included monthly counselling sessions with drug‐level feedback (DLF) plus optional daily short message service (SMS) reminders, weekly phone or SMS check‐ins, peer support clubs, “peer buddies” and additional counselling. Counsellors documented adherence support choices and counselling content on standardized forms. Through focus groups, serial in‐depth interviews (IDIs) and single IDIs (n = 119 total), we explored participants’ experiences with adherence support and how it encouraged product use.
Results
Participants received counselling at nearly all visits. DLF was provided at 54.3% of sessions and, across sites, 49%–68% received results showing high adherence for oral PrEP, and 73%–89% for the ring. The most popular support strategies were in‐person clubs and weekly calls, followed by online clubs, additional counselling and SMS. Preferences differed across sites but were similar for both products. Qualitative results demonstrated that the REACH strategies supported adherence by providing information about HIV and PrEP, continually motivating participants, and supporting the development of behavioural skills and self‐efficacy, aligning with the Information, Motivation, and Behavioural Skills (IMB) model. Effectiveness was supported by three foundational pillars: strong interpersonal relationships with counsellors; ongoing, easily accessible support and resources; and establishing trust in the counsellors and study products through counsellor relationships, peer‐to‐peer exchange and DLF.
Conclusions
Implementation programmes could support effective PrEP use by offering a small menu of counsellor‐ and peer‐based support options that are youth‐friendly and developmentally appropriate. The same menu options can support both ring and oral PrEP users, though content should be tailored to the individual products. |
---|---|
AbstractList | Effective use of pre-exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub-Saharan Africa. The MTN-034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine vaginal ring. Understanding how these strategies promoted product use could inform the design of adherence support systems in programmatic settings.INTRODUCTIONEffective use of pre-exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub-Saharan Africa. The MTN-034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine vaginal ring. Understanding how these strategies promoted product use could inform the design of adherence support systems in programmatic settings.REACH was a randomized crossover trial evaluating the safety of and adherence to the ring and oral PrEP among 247 HIV-negative AGYW (ages 16-21) in South Africa, Uganda and Zimbabwe from January 2019 to September 2021 (NCT03593655). Adherence support included monthly counselling sessions with drug-level feedback (DLF) plus optional daily short message service (SMS) reminders, weekly phone or SMS check-ins, peer support clubs, "peer buddies" and additional counselling. Counsellors documented adherence support choices and counselling content on standardized forms. Through focus groups, serial in-depth interviews (IDIs) and single IDIs (n = 119 total), we explored participants' experiences with adherence support and how it encouraged product use.METHODSREACH was a randomized crossover trial evaluating the safety of and adherence to the ring and oral PrEP among 247 HIV-negative AGYW (ages 16-21) in South Africa, Uganda and Zimbabwe from January 2019 to September 2021 (NCT03593655). Adherence support included monthly counselling sessions with drug-level feedback (DLF) plus optional daily short message service (SMS) reminders, weekly phone or SMS check-ins, peer support clubs, "peer buddies" and additional counselling. Counsellors documented adherence support choices and counselling content on standardized forms. Through focus groups, serial in-depth interviews (IDIs) and single IDIs (n = 119 total), we explored participants' experiences with adherence support and how it encouraged product use.Participants received counselling at nearly all visits. DLF was provided at 54.3% of sessions and, across sites, 49%-68% received results showing high adherence for oral PrEP, and 73%-89% for the ring. The most popular support strategies were in-person clubs and weekly calls, followed by online clubs, additional counselling and SMS. Preferences differed across sites but were similar for both products. Qualitative results demonstrated that the REACH strategies supported adherence by providing information about HIV and PrEP, continually motivating participants, and supporting the development of behavioural skills and self-efficacy, aligning with the Information, Motivation, and Behavioural Skills (IMB) model. Effectiveness was supported by three foundational pillars: strong interpersonal relationships with counsellors; ongoing, easily accessible support and resources; and establishing trust in the counsellors and study products through counsellor relationships, peer-to-peer exchange and DLF.RESULTSParticipants received counselling at nearly all visits. DLF was provided at 54.3% of sessions and, across sites, 49%-68% received results showing high adherence for oral PrEP, and 73%-89% for the ring. The most popular support strategies were in-person clubs and weekly calls, followed by online clubs, additional counselling and SMS. Preferences differed across sites but were similar for both products. Qualitative results demonstrated that the REACH strategies supported adherence by providing information about HIV and PrEP, continually motivating participants, and supporting the development of behavioural skills and self-efficacy, aligning with the Information, Motivation, and Behavioural Skills (IMB) model. Effectiveness was supported by three foundational pillars: strong interpersonal relationships with counsellors; ongoing, easily accessible support and resources; and establishing trust in the counsellors and study products through counsellor relationships, peer-to-peer exchange and DLF.Implementation programmes could support effective PrEP use by offering a small menu of counsellor- and peer-based support options that are youth-friendly and developmentally appropriate. The same menu options can support both ring and oral PrEP users, though content should be tailored to the individual products.CONCLUSIONSImplementation programmes could support effective PrEP use by offering a small menu of counsellor- and peer-based support options that are youth-friendly and developmentally appropriate. The same menu options can support both ring and oral PrEP users, though content should be tailored to the individual products. Introduction: Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The MTN‐034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine vaginal ring. Understanding how these strategies promoted product use could inform the design of adherence support systems in programmatic settings. Methods: REACH was a randomized crossover trial evaluating the safety of and adherence to the ring and oral PrEP among 247 HIV‐negative AGYW (ages 16–21) in South Africa, Uganda and Zimbabwe from January 2019 to September 2021 (NCT03593655). Adherence support included monthly counselling sessions with drug‐level feedback (DLF) plus optional daily short message service (SMS) reminders, weekly phone or SMS check‐ins, peer support clubs, “peer buddies” and additional counselling. Counsellors documented adherence support choices and counselling content on standardized forms. Through focus groups, serial in‐depth interviews (IDIs) and single IDIs (n = 119 total), we explored participants’ experiences with adherence support and how it encouraged product use. Results: Participants received counselling at nearly all visits. DLF was provided at 54.3% of sessions and, across sites, 49%–68% received results showing high adherence for oral PrEP, and 73%–89% for the ring. The most popular support strategies were in‐person clubs and weekly calls, followed by online clubs, additional counselling and SMS. Preferences differed across sites but were similar for both products. Qualitative results demonstrated that the REACH strategies supported adherence by providing information about HIV and PrEP, continually motivating participants, and supporting the development of behavioural skills and self‐efficacy, aligning with the Information, Motivation, and Behavioural Skills (IMB) model. Effectiveness was supported by three foundational pillars: strong interpersonal relationships with counsellors; ongoing, easily accessible support and resources; and establishing trust in the counsellors and study products through counsellor relationships, peer‐to‐peer exchange and DLF. Conclusions: Implementation programmes could support effective PrEP use by offering a small menu of counsellor‐ and peer‐based support options that are youth‐friendly and developmentally appropriate. The same menu options can support both ring and oral PrEP users, though content should be tailored to the individual products. Abstract Introduction Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The MTN‐034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine vaginal ring. Understanding how these strategies promoted product use could inform the design of adherence support systems in programmatic settings. Methods REACH was a randomized crossover trial evaluating the safety of and adherence to the ring and oral PrEP among 247 HIV‐negative AGYW (ages 16–21) in South Africa, Uganda and Zimbabwe from January 2019 to September 2021 (NCT03593655). Adherence support included monthly counselling sessions with drug‐level feedback (DLF) plus optional daily short message service (SMS) reminders, weekly phone or SMS check‐ins, peer support clubs, “peer buddies” and additional counselling. Counsellors documented adherence support choices and counselling content on standardized forms. Through focus groups, serial in‐depth interviews (IDIs) and single IDIs (n = 119 total), we explored participants’ experiences with adherence support and how it encouraged product use. Results Participants received counselling at nearly all visits. DLF was provided at 54.3% of sessions and, across sites, 49%–68% received results showing high adherence for oral PrEP, and 73%–89% for the ring. The most popular support strategies were in‐person clubs and weekly calls, followed by online clubs, additional counselling and SMS. Preferences differed across sites but were similar for both products. Qualitative results demonstrated that the REACH strategies supported adherence by providing information about HIV and PrEP, continually motivating participants, and supporting the development of behavioural skills and self‐efficacy, aligning with the Information, Motivation, and Behavioural Skills (IMB) model. Effectiveness was supported by three foundational pillars: strong interpersonal relationships with counsellors; ongoing, easily accessible support and resources; and establishing trust in the counsellors and study products through counsellor relationships, peer‐to‐peer exchange and DLF. Conclusions Implementation programmes could support effective PrEP use by offering a small menu of counsellor‐ and peer‐based support options that are youth‐friendly and developmentally appropriate. The same menu options can support both ring and oral PrEP users, though content should be tailored to the individual products. IntroductionEffective use of pre-exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub-Saharan Africa. The MTN-034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine vaginal ring. Understanding how these strategies promoted product use could inform the design of adherence support systems in programmatic settings.MethodsREACH was a randomized crossover trial evaluating the safety of and adherence to the ring and oral PrEP among 247 HIV-negative AGYW (ages 16–21) in South Africa, Uganda and Zimbabwe from January 2019 to September 2021 (NCT03593655). Adherence support included monthly counselling sessions with drug-level feedback (DLF) plus optional daily short message service (SMS) reminders, weekly phone or SMS check-ins, peer support clubs, “peer buddies” and additional counselling. Counsellors documented adherence support choices and counselling content on standardized forms. Through focus groups, serial in-depth interviews (IDIs) and single IDIs (n = 119 total), we explored participants’ experiences with adherence support and how it encouraged product use.ResultsParticipants received counselling at nearly all visits. DLF was provided at 54.3% of sessions and, across sites, 49%–68% received results showing high adherence for oral PrEP, and 73%–89% for the ring. The most popular support strategies were in-person clubs and weekly calls, followed by online clubs, additional counselling and SMS. Preferences differed across sites but were similar for both products. Qualitative results demonstrated that the REACH strategies supported adherence by providing information about HIV and PrEP, continually motivating participants, and supporting the development of behavioural skills and self-efficacy, aligning with the Information, Motivation, and Behavioural Skills (IMB) model. Effectiveness was supported by three foundational pillars: strong interpersonal relationships with counsellors; ongoing, easily accessible support and resources; and establishing trust in the counsellors and study products through counsellor relationships, peer-to-peer exchange and DLF.ConclusionsImplementation programmes could support effective PrEP use by offering a small menu of counsellor- and peer-based support options that are youth-friendly and developmentally appropriate. The same menu options can support both ring and oral PrEP users, though content should be tailored to the individual products. Effective use of pre-exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub-Saharan Africa. The MTN-034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine vaginal ring. Understanding how these strategies promoted product use could inform the design of adherence support systems in programmatic settings. REACH was a randomized crossover trial evaluating the safety of and adherence to the ring and oral PrEP among 247 HIV-negative AGYW (ages 16-21) in South Africa, Uganda and Zimbabwe from January 2019 to September 2021 (NCT03593655). Adherence support included monthly counselling sessions with drug-level feedback (DLF) plus optional daily short message service (SMS) reminders, weekly phone or SMS check-ins, peer support clubs, "peer buddies" and additional counselling. Counsellors documented adherence support choices and counselling content on standardized forms. Through focus groups, serial in-depth interviews (IDIs) and single IDIs (n = 119 total), we explored participants' experiences with adherence support and how it encouraged product use. Participants received counselling at nearly all visits. DLF was provided at 54.3% of sessions and, across sites, 49%-68% received results showing high adherence for oral PrEP, and 73%-89% for the ring. The most popular support strategies were in-person clubs and weekly calls, followed by online clubs, additional counselling and SMS. Preferences differed across sites but were similar for both products. Qualitative results demonstrated that the REACH strategies supported adherence by providing information about HIV and PrEP, continually motivating participants, and supporting the development of behavioural skills and self-efficacy, aligning with the Information, Motivation, and Behavioural Skills (IMB) model. Effectiveness was supported by three foundational pillars: strong interpersonal relationships with counsellors; ongoing, easily accessible support and resources; and establishing trust in the counsellors and study products through counsellor relationships, peer-to-peer exchange and DLF. Implementation programmes could support effective PrEP use by offering a small menu of counsellor- and peer-based support options that are youth-friendly and developmentally appropriate. The same menu options can support both ring and oral PrEP users, though content should be tailored to the individual products. Abstract Introduction Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The MTN‐034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine vaginal ring. Understanding how these strategies promoted product use could inform the design of adherence support systems in programmatic settings. Methods REACH was a randomized crossover trial evaluating the safety of and adherence to the ring and oral PrEP among 247 HIV‐negative AGYW (ages 16–21) in South Africa, Uganda and Zimbabwe from January 2019 to September 2021 (NCT03593655). Adherence support included monthly counselling sessions with drug‐level feedback (DLF) plus optional daily short message service (SMS) reminders, weekly phone or SMS check‐ins, peer support clubs, “peer buddies” and additional counselling. Counsellors documented adherence support choices and counselling content on standardized forms. Through focus groups, serial in‐depth interviews (IDIs) and single IDIs ( n = 119 total), we explored participants’ experiences with adherence support and how it encouraged product use. Results Participants received counselling at nearly all visits. DLF was provided at 54.3% of sessions and, across sites, 49%–68% received results showing high adherence for oral PrEP, and 73%–89% for the ring. The most popular support strategies were in‐person clubs and weekly calls, followed by online clubs, additional counselling and SMS. Preferences differed across sites but were similar for both products. Qualitative results demonstrated that the REACH strategies supported adherence by providing information about HIV and PrEP, continually motivating participants, and supporting the development of behavioural skills and self‐efficacy, aligning with the Information, Motivation, and Behavioural Skills (IMB) model. Effectiveness was supported by three foundational pillars: strong interpersonal relationships with counsellors; ongoing, easily accessible support and resources; and establishing trust in the counsellors and study products through counsellor relationships, peer‐to‐peer exchange and DLF. Conclusions Implementation programmes could support effective PrEP use by offering a small menu of counsellor‐ and peer‐based support options that are youth‐friendly and developmentally appropriate. The same menu options can support both ring and oral PrEP users, though content should be tailored to the individual products. Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The MTN‐034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine vaginal ring. Understanding how these strategies promoted product use could inform the design of adherence support systems in programmatic settings. REACH was a randomized crossover trial evaluating the safety of and adherence to the ring and oral PrEP among 247 HIV‐negative AGYW (ages 16–21) in South Africa, Uganda and Zimbabwe from January 2019 to September 2021 (NCT03593655). Adherence support included monthly counselling sessions with drug‐level feedback (DLF) plus optional daily short message service (SMS) reminders, weekly phone or SMS check‐ins, peer support clubs, “peer buddies” and additional counselling. Counsellors documented adherence support choices and counselling content on standardized forms. Through focus groups, serial in‐depth interviews (IDIs) and single IDIs (n = 119 total), we explored participants’ experiences with adherence support and how it encouraged product use. Implementation programmes could support effective PrEP use by offering a small menu of counsellor‐ and peer‐based support options that are youth‐friendly and developmentally appropriate. The same menu options can support both ring and oral PrEP users, though content should be tailored to the individual products. Introduction Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The MTN‐034/REACH trial offered AGYW a menu of adherence support strategies and achieved high adherence to both daily oral PrEP and the monthly dapivirine vaginal ring. Understanding how these strategies promoted product use could inform the design of adherence support systems in programmatic settings. Methods REACH was a randomized crossover trial evaluating the safety of and adherence to the ring and oral PrEP among 247 HIV‐negative AGYW (ages 16–21) in South Africa, Uganda and Zimbabwe from January 2019 to September 2021 (NCT03593655). Adherence support included monthly counselling sessions with drug‐level feedback (DLF) plus optional daily short message service (SMS) reminders, weekly phone or SMS check‐ins, peer support clubs, “peer buddies” and additional counselling. Counsellors documented adherence support choices and counselling content on standardized forms. Through focus groups, serial in‐depth interviews (IDIs) and single IDIs (n = 119 total), we explored participants’ experiences with adherence support and how it encouraged product use. Results Participants received counselling at nearly all visits. DLF was provided at 54.3% of sessions and, across sites, 49%–68% received results showing high adherence for oral PrEP, and 73%–89% for the ring. The most popular support strategies were in‐person clubs and weekly calls, followed by online clubs, additional counselling and SMS. Preferences differed across sites but were similar for both products. Qualitative results demonstrated that the REACH strategies supported adherence by providing information about HIV and PrEP, continually motivating participants, and supporting the development of behavioural skills and self‐efficacy, aligning with the Information, Motivation, and Behavioural Skills (IMB) model. Effectiveness was supported by three foundational pillars: strong interpersonal relationships with counsellors; ongoing, easily accessible support and resources; and establishing trust in the counsellors and study products through counsellor relationships, peer‐to‐peer exchange and DLF. Conclusions Implementation programmes could support effective PrEP use by offering a small menu of counsellor‐ and peer‐based support options that are youth‐friendly and developmentally appropriate. The same menu options can support both ring and oral PrEP users, though content should be tailored to the individual products. |
Audience | Academic |
Author | Nabunya, Hadijah Kalule Mvinjelwa, Priscilla Roberts, Sarah T. Soto‐Torres, Lydia Mancuso, Noah Mposula, Hlengiwe Ngure, Kenneth Williams, Kristin Hosek, Sybil Szydlo, Daniel W. Mugocha, Caroline Garcia, Morgan |
Author_xml | – sequence: 1 givenname: Sarah T. orcidid: 0000-0002-3318-9781 surname: Roberts fullname: Roberts, Sarah T. email: sroberts@rti.org organization: Women's Global Health Imperative, RTI International – sequence: 2 givenname: Noah orcidid: 0000-0002-4442-9293 surname: Mancuso fullname: Mancuso, Noah organization: Women's Global Health Imperative, RTI International – sequence: 3 givenname: Kristin surname: Williams fullname: Williams, Kristin organization: RTI International – sequence: 4 givenname: Hadijah Kalule surname: Nabunya fullname: Nabunya, Hadijah Kalule organization: Makerere University‐Johns Hopkins University Research Collaboration – sequence: 5 givenname: Hlengiwe surname: Mposula fullname: Mposula, Hlengiwe organization: Wits Reproductive Health and HIV Institute – sequence: 6 givenname: Caroline surname: Mugocha fullname: Mugocha, Caroline organization: University of Zimbabwe Clinical Trials Research Centre – sequence: 7 givenname: Priscilla surname: Mvinjelwa fullname: Mvinjelwa, Priscilla organization: Desmond Tutu HIV Centre – sequence: 8 givenname: Morgan surname: Garcia fullname: Garcia, Morgan organization: FHI 360 – sequence: 9 givenname: Daniel W. surname: Szydlo fullname: Szydlo, Daniel W. organization: Fred Hutchinson Cancer Center – sequence: 10 givenname: Lydia surname: Soto‐Torres fullname: Soto‐Torres, Lydia organization: National Institute of Allergy and Infectious Diseases, National Institutes of Health – sequence: 11 givenname: Kenneth orcidid: 0000-0002-8062-0933 surname: Ngure fullname: Ngure, Kenneth organization: University of Washington – sequence: 12 givenname: Sybil surname: Hosek fullname: Hosek, Sybil organization: University of Illinois Chicago |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37936551$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kt2O1CAUxxuzxv3QGx_AkJgYYzIj0BaKd5ONOmM28cKP24bCacukhRFax7nzEXwdX8cnke6s66yZGC6Aw-_8Dxz-58mJdRaS5DHBc4Ixfbk2ks4pI4W4l5wRnhczynJ6crA-Tc5DWGPMaJGJB8lpykXK8pycJT-Xbosk6sGOyNVI6hY8WAUojJuN8wMKg5cDNAYCqqUynRniVqPWNO0BPTi0XH1GGw9fwQ7G2bh0elRDQLJ3tomo6yCoeIga47sYthrt3BiPti5WR8bGktWv7z8-yFZ6adGi9kbJV9PlzLdYsYehdXpKlN0umPAwuV_LLsCjm_ki-fTm9cfL5ezq_dvV5eJqpnKRi5nmeYZ5lSuWca5pqllViCKXWHKBa6ZTICkH0KkktKp4ptO6YjyjDHNeAcnSi2S119VOrsuNN730u9JJU14HnG9K6QejOigLUmWpUlmKqzTDmBeUElUAk4UQtQYctZ7vtWJ3vowQhrI3sSldJy24MZS0KHjGc05ERJ_-g67d6OPbJ0pkhPE8Lf5SjYz1ja1d_C41iZYLLghmWFAWqdkRqgELXnbRS7WJ4Tv8_Agfh4beqKMJzw4SWpDd0AbXjZMTwl3wxR5U3oXgob5tKMHlZOZyMnN5beYIP7lpwVj1oG_RP-6NANkD23if3X-kynerBd2L_gbMLv_f |
CitedBy_id | crossref_primary_10_1002_jia2_26213 crossref_primary_10_1002_jia2_26217 crossref_primary_10_1002_jia2_26255 crossref_primary_10_1097_MOP_0000000000001357 |
Cites_doi | 10.1007/s10461-016-1609-1 10.1007/s10461-021-03391-w 10.1186/s12879-018-3463-4 10.1186/s12913-018-3623-7 10.1007/s10461-021-03231-x 10.1007/s10461-018-02387-3 10.1007/s10461-018-2371-3 10.1186/s12978-021-01183-y 10.1097/QAD.0000000000001145 10.1371/journal.pmed.1003670 10.1089/aid.2012.0089 10.1056/NEJMoa1602046 10.1002/jia2.25909 10.1080/09540121.2018.1515471 10.1016/S0140-6736(07)60371-7 10.1371/journal.pone.0258542 10.1111/hiv.12132 10.7448/IAS.19.7.21107 10.1097/QAD.0000000000000647 10.1128/AAC.01710-17 10.1097/COH.0b013e3283590632 10.1001/jama.2019.2591 10.1007/s10461-018-2095-4 10.1186/s12889-021-11335-1 10.1002/jia2.25636 10.1007/s10461-020-03026-6 10.1016/j.jpba.2016.03.023 10.1080/16549716.2018.1536412 10.1097/QAI.0000000000001830 10.1371/journal.pone.0189770 10.1016/S0140-6736(11)60878-7 10.1097/QAI.0b013e3182801081 10.1002/jia2.25962 10.1097/QAD.0000000000002777 10.1097/QAD.0000000000001868 10.1002/jia2.25634 10.1002/jia2.25298 10.1016/S1473-3099(14)70847-3 10.1007/s10461-022-03663-z 10.1007/s11904-019-00431-y 10.2147/IJWH.S185712 10.1080/15381501.2013.773575 10.1089/apc.2013.0085 10.1371/journal.pmed.1004097 10.1007/s10461-021-03286-w 10.1007/s10461-022-03588-7 10.2337/dc13-0816 10.1097/QAI.0000000000001179 10.1016/S2352-3018(20)30307-6 10.1002/jia2.25463 10.1089/apc.2014.0273 10.1056/NEJMoa1506110 10.1097/QAD.0000000000003500 10.1007/s10461-018-2034-4 10.1097/JNC.0000000000000350 10.1016/j.jadohealth.2012.12.014 10.1037/0033-2909.111.3.455 10.1007/s10461-016-1650-0 10.1177/1558689810382916 10.1007/s10508-020-01880-y 10.1016/j.jadohealth.2016.03.014 10.1016/S0005-7967(00)00091-7 10.1007/BF02506983 10.1177/1359105311398727 10.1016/S2352-3018(20)30304-0 10.1097/QAD.0000000000001452 10.1007/s10461-023-04109-w 10.1016/S2352-4642(20)30248-0 10.1016/S2352-3018(23)00227-8 10.1002/jia2.26069 10.1371/journal.pone.0287525 10.1093/cid/ciy810 |
ContentType | Journal Article |
Copyright | 2023 The Authors. published by John Wiley & Sons Ltd on behalf of International AIDS Society. 2023 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of International AIDS Society. COPYRIGHT 2023 John Wiley & Sons, Inc. 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2023 The Authors. published by John Wiley & Sons Ltd on behalf of International AIDS Society. – notice: 2023 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of International AIDS Society. – notice: COPYRIGHT 2023 John Wiley & Sons, Inc. – notice: 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P WIN CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO FYUFA GHDGH K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 DOA |
DOI | 10.1002/jia2.26189 |
DatabaseName | Wiley Online Library Open Access Wiley Online Library Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College Coronavirus Research Database ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) Coronavirus Research Database ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 24P name: Wiley Online Library url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1758-2652 |
EndPage | n/a |
ExternalDocumentID | oai_doaj_org_article_81b43cc430b340078221c8e6a899fde0 A791060926 10_1002_jia2_26189 37936551 JIA226189 |
Genre | article Randomized Controlled Trial Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | South Africa Zimbabwe Sub-Saharan Africa Uganda Kenya Africa |
GeographicLocations_xml | – name: South Africa – name: Zimbabwe – name: Sub-Saharan Africa – name: Uganda – name: Kenya – name: Africa |
GrantInformation_xml | – fundername: National Institute of Allergy and Infectious Diseases funderid: UM1AI068615; UM1AI068633; UM1AI106707 – fundername: National Institute of Mental Health – fundername: Eunice Kennedy Shriver National Institute of Child Health and Human Development – fundername: NIAID NIH HHS grantid: UM1 AI068615 – fundername: NIAID NIH HHS grantid: UM1 AI069463 – fundername: NIAID NIH HHS grantid: U01 AI068633 – fundername: NIAID NIH HHS grantid: U01 AI069463 – fundername: NIMH NIH HHS – fundername: NIAID NIH HHS grantid: UM1 AI106707 |
GroupedDBID | --- -5E -5G -BR 0R~ 1OC 24P 29L 2VQ 2WC 3V. 4.4 53G 5GY 5VS 7X7 88E 8FI 8FJ AAHHS ABDBF ABUWG ACCFJ ACGFO ACGFS ACRMQ ACXQS ADBBV ADINQ ADKYN ADPDF ADRAZ ADUKV ADZMN AEEZP AEGXH AENEX AEQDE AFGXO AFKRA AHBYD AHMBA AIAGR AIWBW AJBDE ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AMKLP AOIJS AVUZU BAWUL BCNDV BENPR BMC BPHCQ BVXVI C24 C6C CCPQU DIK E3Z EBD EBS EJD EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO ICW IEA IHR IHW INH INR IOF ITC KQ8 M1P M48 M~E N8Y O5R O5S O9- OK1 OVD OVEED P2P PIMPY PQQKQ PROAC PSQYO RNS ROL RPM RSV SMD SOJ SV3 TEORI TR2 TUS UKHRP WIN CGR CUY CVF ECM EIF NPM AAYXX CITATION 7XB 8FK AZQEC COVID DWQXO K9. PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-c5959-d75407b5c6477d23d6b8985a0a790f6d3e137eed3a12bb74d3fb67426077be143 |
IEDL.DBID | COVID |
ISSN | 1758-2652 |
IngestDate | Tue Oct 22 15:16:45 EDT 2024 Wed Oct 16 16:45:24 EDT 2024 Thu Oct 10 22:49:54 EDT 2024 Thu Jun 13 23:58:07 EDT 2024 Tue Oct 22 21:18:00 EDT 2024 Tue Jun 04 11:53:00 EDT 2024 Tue Aug 20 22:14:30 EDT 2024 Thu Sep 12 16:53:46 EDT 2024 Wed Oct 23 09:54:28 EDT 2024 Sat Aug 24 01:00:21 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | pre-exposure prophylaxis sub-Saharan Africa HIV adolescents medication adherence psychosocial intervention female |
Language | English |
License | Attribution 2023 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of International AIDS Society. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5959-d75407b5c6477d23d6b8985a0a790f6d3e137eed3a12bb74d3fb67426077be143 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
ORCID | 0000-0002-4442-9293 0000-0002-8062-0933 0000-0002-3318-9781 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://www.proquest.com/docview/2894167538?pq-origsite=%requestingapplication% |
PMID | 37936551 |
PQID | 2894167538 |
PQPubID | 55048 |
PageCount | 13 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_81b43cc430b340078221c8e6a899fde0 proquest_miscellaneous_2887475719 proquest_journals_2894167538 gale_infotracmisc_A791060926 gale_infotracgeneralonefile_A791060926 gale_infotracacademiconefile_A791060926 gale_healthsolutions_A791060926 crossref_primary_10_1002_jia2_26189 pubmed_primary_37936551 wiley_primary_10_1002_jia2_26189_JIA226189 |
PublicationCentury | 2000 |
PublicationDate | November 2023 2023-11-00 20231101 2023-11-01 |
PublicationDateYYYYMMDD | 2023-11-01 |
PublicationDate_xml | – month: 11 year: 2023 text: November 2023 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Geneva |
PublicationTitle | Journal of the International AIDS Society |
PublicationTitleAlternate | J Int AIDS Soc |
PublicationYear | 2023 |
Publisher | John Wiley & Sons, Inc Wiley |
Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley |
References | 2021; 25 2013; 29 2021; 21 2023; 37 2019; 11 2013; 62 2019; 16 2016; 30 2022; 25 2022; 26 2014; 28 2011; 16 2019; 321 2021; 35 2017; 31 2017; 74 2020; 4 2019; 22 2023; 26 2013; 12 1992; 111 2019; 68 1995; 23 2019; 23 2013; 52 2014; 15 2014; 14 2018; 30 2022; 33 2018; 32 2010; 4 2018; 79 2021; 8 2011; 378 2007; 369 2016; 19 2012 2023; 18 2017; 21 2018; 62 2016; 125 2002 2021; 50 2018; 22 2016; 59 1999 2018; 18 2021; 16 2015; 29 2023 2022 2021 2021; 18 2014; 37 2019 2018 2016; 375 2017 2016 2020; 23 2015 2001; 39 2012; 7 2018; 11 2022; 19 2018; 13 e_1_2_12_4_1 e_1_2_12_6_1 e_1_2_12_19_1 e_1_2_12_2_1 e_1_2_12_17_1 e_1_2_12_38_1 e_1_2_12_20_1 e_1_2_12_41_1 e_1_2_12_66_1 e_1_2_12_22_1 e_1_2_12_43_1 e_1_2_12_64_1 e_1_2_12_85_1 e_1_2_12_24_1 e_1_2_12_45_1 e_1_2_12_26_1 e_1_2_12_47_1 e_1_2_12_62_1 e_1_2_12_83_1 e_1_2_12_60_1 e_1_2_12_81_1 e_1_2_12_28_1 e_1_2_12_49_1 e_1_2_12_31_1 e_1_2_12_52_1 e_1_2_12_77_1 e_1_2_12_33_1 e_1_2_12_54_1 e_1_2_12_75_1 e_1_2_12_35_1 e_1_2_12_56_1 e_1_2_12_37_1 e_1_2_12_58_1 e_1_2_12_79_1 e_1_2_12_14_1 e_1_2_12_12_1 e_1_2_12_8_1 e_1_2_12_10_1 e_1_2_12_73_1 e_1_2_12_50_1 e_1_2_12_71_1 e_1_2_12_3_1 e_1_2_12_5_1 e_1_2_12_18_1 e_1_2_12_16_1 e_1_2_12_39_1 e_1_2_12_42_1 e_1_2_12_65_1 e_1_2_12_21_1 e_1_2_12_44_1 e_1_2_12_63_1 e_1_2_12_86_1 e_1_2_12_23_1 e_1_2_12_46_1 e_1_2_12_69_1 e_1_2_12_25_1 e_1_2_12_48_1 e_1_2_12_67_1 e_1_2_12_80_1 e_1_2_12_61_1 e_1_2_12_84_1 e_1_2_12_40_1 e_1_2_12_82_1 e_1_2_12_27_1 e_1_2_12_29_1 Steiberg L (e_1_2_12_68_1) 1999 e_1_2_12_30_1 e_1_2_12_53_1 e_1_2_12_76_1 e_1_2_12_32_1 e_1_2_12_55_1 e_1_2_12_74_1 e_1_2_12_34_1 e_1_2_12_57_1 e_1_2_12_36_1 e_1_2_12_59_1 e_1_2_12_78_1 e_1_2_12_15_1 e_1_2_12_13_1 e_1_2_12_11_1 e_1_2_12_72_1 e_1_2_12_7_1 e_1_2_12_51_1 e_1_2_12_70_1 e_1_2_12_9_1 |
References_xml | – volume: 39 start-page: 1151 issue: 10 year: 2001 end-page: 1162 article-title: Two strategies to increase adherence to HIV antiretroviral medication: life‐steps and medication monitoring publication-title: Behav Res Ther – volume: 74 start-page: 21 issue: 1 year: 2017 end-page: 29 article-title: An HIV preexposure prophylaxis demonstration project and safety study for young MSM publication-title: J Acquir Immune Defic Syndr – volume: 25 issue: 7 year: 2022 article-title: PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project publication-title: J Int AIDS Soc – volume: 321 start-page: 2214 issue: 22 year: 2019 end-page: 2230 article-title: Preexposure prophylaxis for the prevention of HIV infection: evidence report and systematic review for the US Preventive Services Task Force publication-title: JAMA – volume: 37 start-page: 977 issue: 6 year: 2023 end-page: 986 article-title: Longitudinal patterns of initiation, persistence, and cycling on preexposure prophylaxis among female sex workers and adolescent girls and young women in South Africa publication-title: AIDS – volume: 8 start-page: e130 issue: 3 year: 2021 end-page: e137 article-title: Effect of SMS reminders on PrEP adherence in young Kenyan women (MPYA study): a randomised controlled trial publication-title: Lancet HIV – volume: 16 start-page: 1071 issue: 7 year: 2011 end-page: 1081 article-title: A situated‐Information Motivation Behavioral Skills Model of Care Initiation and Maintenance (sIMB‐CIM): an IMB model based approach to understanding and intervening in engagement in care for chronic medical conditions publication-title: J Health Psychol – volume: 14 start-page: 820 issue: 9 year: 2014 end-page: 829 article-title: Uptake of pre‐exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study publication-title: Lancet Infect Dis – volume: 26 issue: 3 year: 2023 article-title: Uptake and continuation of HIV pre‐exposure prophylaxis among women of reproductive age in two health facilities in Kisumu County, Kenya publication-title: J Int AIDS Soc. – year: 2021 – volume: 26 start-page: 375 issue: 2 year: 2022 end-page: 384 article-title: HIV prevention and treatment behavior change and the situated Information Motivation Behavioral Skills (sIMB) model: a qualitative evaluation of a community health worker intervention in Rakai, Uganda publication-title: AIDS Behav. – volume: 26 start-page: 2494 issue: 7 year: 2022 end-page: 2502 article-title: Assessing the information‐motivation‐behavioral skills model to predict pre‐exposure prophylaxis adherence among black men who have sex with men and transgender women in a community setting in New York City publication-title: AIDS Behav – volume: 50 start-page: 1729 issue: 4 year: 2021 end-page: 1742 article-title: Exploring perceived barriers and facilitators of PrEP uptake among young people in Uganda, Zimbabwe, and South Africa publication-title: Arch Sex Behav – volume: 29 start-page: 1277 issue: 11 year: 2015 end-page: 1285 article-title: Defining success with HIV pre‐exposure prophylaxis: a prevention‐effective adherence paradigm publication-title: AIDS – year: 2021 article-title: Adherence to the dapivirine vaginal ring and oral PrEP among adolescent girls and young women in Africa: interim results from the REACH study – volume: 32 start-page: 1517 issue: 11 year: 2018 end-page: 1525 article-title: Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug‐level results publication-title: AIDS – volume: 79 start-page: 458 issue: 4 year: 2018 end-page: 466 article-title: Comparing youth‐friendly health services to the standard of care through “Girl Power‐Malawi”: a quasi‐experimental cohort study publication-title: J Acquir Immune Defic Syndr – year: 2018 – volume: 22 year: 2019 article-title: HIV pre‐exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery publication-title: J Int AIDS Soc – volume: 375 start-page: 2133 issue: 22 year: 2016 end-page: 2143 article-title: Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women publication-title: N Engl J Med – volume: 25 start-page: 721 issue: 3 year: 2021 end-page: 731 article-title: Sharing objective measures of adherence to a vaginal microbicide promotes candor about actual use and bolsters motivation to prevent HIV publication-title: AIDS Behav – volume: 13 issue: 1 year: 2018 article-title: Interventions to improve antiretroviral therapy adherence among adolescents in low‐ and middle‐income countries: a systematic review of the literature publication-title: PLoS One – volume: 21 start-page: 1299 issue: 5 year: 2017 end-page: 1308 article-title: Willingness to use pre‐exposure prophylaxis (PrEP): an empirical test of the Information‐Motivation‐Behavioral Skills (IMB) model among high‐risk drug users in treatment publication-title: AIDS Behav – volume: 23 start-page: 2185 issue: 8 year: 2019 end-page: 2189 article-title: Debrief reports to expedite the impact of qualitative research: do they accurately capture data from in‐depth interviews? publication-title: AIDS Behav – volume: 23 issue: 11 year: 2020 article-title: Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial publication-title: J Int AIDS Soc – volume: 16 issue: 10 year: 2021 article-title: Adolescent girls and young women's PrEP‐user journey during an implementation science study in South Africa and Kenya publication-title: PLoS One – volume: 125 start-page: 94 year: 2016 end-page: 100 article-title: Post‐use assay of vaginal rings (VRs) as a potential measure of clinical trial adherence publication-title: J Pharm Biomed Anal – year: 2022 article-title: Evaluating adaptive HIV pre‐exposure prophylaxis adherence interventions for young South African women: results from a sequential multiple assignment randomized trial – volume: 18 start-page: 581 issue: 1 year: 2018 article-title: A systematic review of adherence to oral pre‐exposure prophylaxis for HIV—how can we improve uptake and adherence? publication-title: BMC Infect Dis – volume: 25 issue: 5 year: 2022 article-title: Oral pre‐exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study publication-title: J Int AIDS Soc – volume: 31 start-page: 1159 issue: 8 year: 2017 end-page: 1167 article-title: Acceptability and use of a dapivirine vaginal ring in a phase III trial publication-title: AIDS – volume: 4 start-page: 875 issue: 12 year: 2020 end-page: 883 article-title: Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre‐exposure prophylaxis in South African adolescents: an open‐label single‐arm phase 2 trial publication-title: Lancet Child Adolesc Health – year: 2018 article-title: Empowerment clubs did not increase PrEP continuation among adolescent girls and young women in South Africa and Tanzania—results from the EMPOWER randomised trial – volume: 22 start-page: 2650 issue: 8 year: 2018 end-page: 2661 article-title: Project ACCEPT: evaluation of a group‐based intervention to improve engagement in care for youth newly diagnosed with HIV publication-title: AIDS Behav – volume: 19 issue: 7 year: 2016 article-title: Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa publication-title: J Int AIDS Soc – volume: 11 start-page: 97 year: 2019 end-page: 107 article-title: We are not the same”: African women's view of multipurpose prevention products in the TRIO clinical study publication-title: Int J Women's Health – volume: 18 issue: 6 year: 2023 article-title: Baseline preferences for oral pre‐exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe publication-title: PLoS One – volume: 23 issue: 11 year: 2020 article-title: Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial publication-title: J Int AIDS Soc – volume: 369 start-page: 1565 issue: 9572 year: 2007 end-page: 1573 article-title: Youth‐friendly primary‐care services: how are we doing and what more needs to be done? publication-title: Lancet – volume: 21 start-page: 481 issue: 2 year: 2017 end-page: 491 article-title: Misreporting of product adherence in the MTN‐003/VOICE trial for HIV prevention in Africa: participants' explanations for dishonesty publication-title: AIDS Behav – year: 2023 article-title: Adolescent girls and young women's experiences with disclosing oral PrEP or dapivirine vaginal ring use: a multi‐country qualitative analysis publication-title: AIDS Behav – volume: 8 start-page: e87 issue: 2 year: 2021 end-page: e95 article-title: Safety, uptake, and use of a dapivirine vaginal ring for HIV‐1 prevention in African women (HOPE): an open‐label, extension study publication-title: Lancet HIV – volume: 16 start-page: 120 issue: 1 year: 2019 end-page: 128 article-title: HIV prevention interventions for adolescents publication-title: Curr HIV/AIDS Rep – volume: 19 issue: 9 year: 2022 article-title: Continued attendance in a PrEP program despite low adherence and non‐protective drug levels among adolescent girls and young women in Kenya: results from a prospective cohort study publication-title: PLoS Med – volume: 23 issue: 3 year: 2020 article-title: The influence of HIV‐related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study publication-title: J Int AIDS Soc – year: 2019 – volume: 18 start-page: 135 issue: 1 year: 2021 article-title: Factors influencing access to and utilisation of youth‐friendly sexual and reproductive health services in sub‐Saharan Africa: a systematic review publication-title: Reprod Health – year: 2015 – volume: 30 start-page: 1973 issue: 12 year: 2016 end-page: 1983 article-title: Effectiveness and safety of oral HIV preexposure prophylaxis for all populations publication-title: AIDS – volume: 22 start-page: 3603 issue: 11 year: 2018 end-page: 3616 article-title: An information‐motivation‐behavioral skills model of PrEP uptake publication-title: AIDS Behav – volume: 15 start-page: 385 issue: 7 year: 2014 end-page: 395 article-title: Helping our patients take HIV pre‐exposure prophylaxis (PrEP): a systematic review of adherence interventions publication-title: HIV Med – volume: 68 start-page: 2010 issue: 12 year: 2019 end-page: 2017 article-title: Randomized controlled trial of a mobile health intervention to promote retention and adherence to preexposure prophylaxis among young people at risk for human immunodeficiency virus: the EPIC study publication-title: Clin Infect Dis – volume: 26 start-page: 3607 issue: 11 year: 2022 end-page: 3619 article-title: Women's experience receiving drug feedback and adherence counseling in MTN‐025/HOPE—an HIV prevention open‐label trial of the dapivirine vaginal ring publication-title: AIDS Behav – volume: 111 start-page: 455 issue: 3 year: 1992 end-page: 474 article-title: Changing AIDS‐risk behavior publication-title: Psychol Bull – volume: 33 start-page: 534 issue: 5 year: 2022 end-page: 541 article-title: Mystery shopper assessment of PrEP service delivery quality for adolescent girls and young women in Kenya: a cross‐sectional study publication-title: J Assoc Nurses AIDS Care – volume: 7 start-page: 534 issue: 6 year: 2012 end-page: 541 article-title: Acceptability in microbicide and PrEP trials: current status and a reconceptualization publication-title: Curr Opin HIV AIDS – volume: 29 start-page: 193 issue: 4 year: 2015 end-page: 203 article-title: Clinician attitudes toward CDC interim pre‐exposure prophylaxis (PrEP) guidance and operationalizing PrEP for adolescents publication-title: AIDS Patient Care STDs – volume: 11 issue: 1 year: 2018 article-title: A systematic review of the use of adolescent mystery clients in assessing the adolescent friendliness of health services in high, middle, and low‐income countries publication-title: Glob Health Action – volume: 18 start-page: 809 issue: 1 year: 2018 article-title: Assessment of adolescent and youth friendly services in primary healthcare facilities in two provinces in South Africa publication-title: BMC Health Serv Res – volume: 21 start-page: 1284 issue: 1 year: 2021 article-title: Facilitators and barriers to HIV pre‐exposure prophylaxis (PrEP) uptake through a community‐based intervention strategy among adolescent girls and young women in Seme Sub‐County, Kisumu, Kenya publication-title: BMC Public Health – volume: 25 start-page: 4169 issue: 12 year: 2021 end-page: 4179 article-title: The influence of perceived dapivirine vaginal ring effectiveness on social disclosure and ring adherence publication-title: AIDS Behav – volume: 28 start-page: 33 issue: 1 year: 2014 end-page: 42 article-title: EVOLUTION–taking charge and growing stronger: the design, acceptability, and feasibility of a secondary prevention empowerment intervention for young women living with HIV publication-title: AIDS Patient Care STDs – volume: 37 start-page: 625 issue: 3 year: 2014 end-page: 633 article-title: A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT‐AD) in patients with uncontrolled type 2 diabetes publication-title: Diabetes Care – year: 2023 article-title: Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre‐exposure prophylaxis among African adolescent girls and young women: a randomised, open‐label, crossover trial publication-title: Lancet HIV – volume: 23 start-page: 1904 issue: 7 year: 2019 end-page: 1916 article-title: Applying the information‐motivation‐behavioral skills model to understand PrEP intentions and use among men who have sex with men publication-title: AIDS Behav – year: 2016 – volume: 25 start-page: 2801 issue: 9 year: 2021 end-page: 2814 article-title: Correlates of adherence to the dapivirine vaginal ring for HIV‐1 prevention publication-title: AIDS Behav – volume: 4 start-page: 342 issue: 4 year: 2010 end-page: 360 article-title: A methodology for conducting integrative mixed methods research and data analyses publication-title: J Mix Methods Res – year: 2012 – volume: 52 start-page: 670 issue: 6 year: 2013 end-page: 681 article-title: Assessment of youth‐friendly health care: a systematic review of indicators drawn from young people's perspectives publication-title: J Adolesc Health – volume: 23 start-page: 581 issue: 5 year: 1995 end-page: 599 article-title: Psychological empowerment: issues and illustrations publication-title: Am J Community Psychol – volume: 12 start-page: 333 issue: 3–4 year: 2013 end-page: 348 article-title: Integrating behavioral HIV interventions into biomedical prevention trials with youth: lessons from Chicago's Project PrEPare publication-title: J HIV AIDS Soc Serv – volume: 378 start-page: 279 issue: 9787 year: 2011 end-page: 281 article-title: Drug concentrations after topical and oral antiretroviral pre‐exposure prophylaxis: implications for HIV prevention in women publication-title: Lancet – volume: 59 start-page: 7 issue: 1 year: 2016 end-page: 16 article-title: Sexually transmitted infection services for adolescents and youth in low‐ and middle‐income countries: perceived and experienced barriers to accessing care publication-title: J Adolesc Health – year: 2002 – volume: 375 start-page: 2121 issue: 22 year: 2016 end-page: 2132 article-title: Use of a vaginal ring containing dapivirine for HIV‐1 prevention in women publication-title: N Engl J Med – volume: 29 start-page: 384 issue: 2 year: 2013 end-page: 390 article-title: Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure publication-title: AIDS Res Hum Retroviruses – volume: 62 issue: 1 year: 2018 article-title: Intracellular tenofovir‐diphosphate and emtricitabine‐triphosphate in dried blood spots following directly observed therapy publication-title: Antimicrob Agents Chemother – volume: 30 start-page: S97 issue: sup5 year: 2018 end-page: S105 article-title: HIV care engagement and ART adherence among Kenyan gay, bisexual, and other men who have sex with men: a multi‐level model informed by qualitative research publication-title: AIDS Care – year: 2017 – volume: 35 start-page: 463 issue: 3 year: 2021 end-page: 475 article-title: Interventions to improve daily medication use among adolescents and young adults: what can we learn for youth pre‐exposure prophylaxis services? publication-title: AIDS – volume: 62 start-page: 447 issue: 4 year: 2013 end-page: 456 article-title: The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men publication-title: J Acquir Immune Defic Syndr – volume: 18 issue: 6 year: 2021 article-title: PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: results from HPTN 082, a randomized controlled trial publication-title: PLoS Med – year: 1999 – ident: e_1_2_12_22_1 doi: 10.1007/s10461-016-1609-1 – ident: e_1_2_12_61_1 doi: 10.1007/s10461-021-03391-w – ident: e_1_2_12_7_1 doi: 10.1186/s12879-018-3463-4 – ident: e_1_2_12_27_1 – ident: e_1_2_12_78_1 doi: 10.1186/s12913-018-3623-7 – ident: e_1_2_12_17_1 doi: 10.1007/s10461-021-03231-x – ident: e_1_2_12_54_1 doi: 10.1007/s10461-018-02387-3 – ident: e_1_2_12_74_1 – ident: e_1_2_12_58_1 doi: 10.1007/s10461-018-2371-3 – ident: e_1_2_12_79_1 doi: 10.1186/s12978-021-01183-y – ident: e_1_2_12_3_1 doi: 10.1097/QAD.0000000000001145 – ident: e_1_2_12_11_1 doi: 10.1371/journal.pmed.1003670 – ident: e_1_2_12_42_1 doi: 10.1089/aid.2012.0089 – ident: e_1_2_12_15_1 doi: 10.1056/NEJMoa1602046 – ident: e_1_2_12_30_1 doi: 10.1002/jia2.25909 – ident: e_1_2_12_57_1 doi: 10.1080/09540121.2018.1515471 – ident: e_1_2_12_71_1 doi: 10.1016/S0140-6736(07)60371-7 – ident: e_1_2_12_18_1 doi: 10.1371/journal.pone.0258542 – ident: e_1_2_12_85_1 doi: 10.1111/hiv.12132 – ident: e_1_2_12_63_1 doi: 10.7448/IAS.19.7.21107 – ident: e_1_2_12_86_1 doi: 10.1097/QAD.0000000000000647 – ident: e_1_2_12_43_1 doi: 10.1128/AAC.01710-17 – ident: e_1_2_12_49_1 doi: 10.1097/COH.0b013e3283590632 – ident: e_1_2_12_6_1 doi: 10.1001/jama.2019.2591 – volume-title: Adolescence year: 1999 ident: e_1_2_12_68_1 contributor: fullname: Steiberg L – ident: e_1_2_12_56_1 doi: 10.1007/s10461-018-2095-4 – ident: e_1_2_12_21_1 doi: 10.1186/s12889-021-11335-1 – ident: e_1_2_12_26_1 – ident: e_1_2_12_14_1 doi: 10.1002/jia2.25636 – ident: e_1_2_12_45_1 doi: 10.1007/s10461-020-03026-6 – ident: e_1_2_12_41_1 doi: 10.1016/j.jpba.2016.03.023 – ident: e_1_2_12_80_1 doi: 10.1080/16549716.2018.1536412 – ident: e_1_2_12_70_1 doi: 10.1097/QAI.0000000000001830 – ident: e_1_2_12_4_1 – ident: e_1_2_12_84_1 doi: 10.1371/journal.pone.0189770 – ident: e_1_2_12_9_1 doi: 10.1016/S0140-6736(11)60878-7 – ident: e_1_2_12_65_1 doi: 10.1097/QAI.0b013e3182801081 – ident: e_1_2_12_75_1 – ident: e_1_2_12_13_1 doi: 10.1002/jia2.25962 – ident: e_1_2_12_83_1 doi: 10.1097/QAD.0000000000002777 – ident: e_1_2_12_24_1 doi: 10.1097/QAD.0000000000001868 – ident: e_1_2_12_5_1 doi: 10.1002/jia2.25634 – ident: e_1_2_12_8_1 doi: 10.1002/jia2.25298 – ident: e_1_2_12_44_1 doi: 10.1016/S1473-3099(14)70847-3 – ident: e_1_2_12_53_1 doi: 10.1007/s10461-022-03663-z – ident: e_1_2_12_69_1 – ident: e_1_2_12_82_1 doi: 10.1007/s11904-019-00431-y – ident: e_1_2_12_2_1 – ident: e_1_2_12_51_1 doi: 10.2147/IJWH.S185712 – ident: e_1_2_12_47_1 – ident: e_1_2_12_38_1 doi: 10.1080/15381501.2013.773575 – ident: e_1_2_12_36_1 doi: 10.1089/apc.2013.0085 – ident: e_1_2_12_12_1 doi: 10.1371/journal.pmed.1004097 – ident: e_1_2_12_23_1 doi: 10.1007/s10461-021-03286-w – ident: e_1_2_12_59_1 doi: 10.1007/s10461-022-03588-7 – ident: e_1_2_12_46_1 – ident: e_1_2_12_40_1 doi: 10.2337/dc13-0816 – ident: e_1_2_12_67_1 doi: 10.1097/QAI.0000000000001179 – ident: e_1_2_12_10_1 doi: 10.1016/S2352-3018(20)30307-6 – ident: e_1_2_12_20_1 doi: 10.1002/jia2.25463 – ident: e_1_2_12_64_1 doi: 10.1089/apc.2014.0273 – ident: e_1_2_12_73_1 – ident: e_1_2_12_16_1 doi: 10.1056/NEJMoa1506110 – ident: e_1_2_12_31_1 doi: 10.1097/QAD.0000000000003500 – ident: e_1_2_12_37_1 doi: 10.1007/s10461-018-2034-4 – ident: e_1_2_12_77_1 doi: 10.1097/JNC.0000000000000350 – ident: e_1_2_12_76_1 – ident: e_1_2_12_72_1 doi: 10.1016/j.jadohealth.2012.12.014 – ident: e_1_2_12_55_1 doi: 10.1037/0033-2909.111.3.455 – ident: e_1_2_12_60_1 doi: 10.1007/s10461-016-1650-0 – ident: e_1_2_12_48_1 doi: 10.1177/1558689810382916 – ident: e_1_2_12_19_1 doi: 10.1007/s10508-020-01880-y – ident: e_1_2_12_81_1 doi: 10.1016/j.jadohealth.2016.03.014 – ident: e_1_2_12_39_1 doi: 10.1016/S0005-7967(00)00091-7 – ident: e_1_2_12_50_1 doi: 10.1007/BF02506983 – ident: e_1_2_12_62_1 doi: 10.1177/1359105311398727 – ident: e_1_2_12_29_1 doi: 10.1016/S2352-3018(20)30304-0 – ident: e_1_2_12_52_1 doi: 10.1097/QAD.0000000000001452 – ident: e_1_2_12_35_1 doi: 10.1007/s10461-023-04109-w – ident: e_1_2_12_66_1 doi: 10.1016/S2352-4642(20)30248-0 – ident: e_1_2_12_28_1 doi: 10.1016/S2352-3018(23)00227-8 – ident: e_1_2_12_32_1 doi: 10.1002/jia2.26069 – ident: e_1_2_12_34_1 doi: 10.1371/journal.pone.0287525 – ident: e_1_2_12_25_1 doi: 10.1093/cid/ciy810 – ident: e_1_2_12_33_1 |
SSID | ssj0062849 |
Score | 2.42052 |
Snippet | Introduction
Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The... Effective use of pre-exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub-Saharan Africa. The MTN-034/REACH trial... Abstract Introduction Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The... Introduction: Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The... Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The MTN‐034/REACH trial... IntroductionEffective use of pre-exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub-Saharan Africa. The... Abstract Introduction Effective use of pre‐exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub‐Saharan Africa. The... |
SourceID | doaj proquest gale crossref pubmed wiley |
SourceType | Open Website Aggregation Database Index Database Publisher |
StartPage | e26189 |
SubjectTerms | Acquired immune deficiency syndrome Adolescent Adolescents AIDS Anti-HIV Agents - therapeutic use Counseling Cross-Over Studies Data collection Disease prevention Empowerment Evaluation Feedback Female Focus groups Girls Health aspects HIV HIV (Viruses) HIV infection HIV Infections - drug therapy HIV Infections - prevention & control Human immunodeficiency virus Humans Interpersonal relations Medical care medication adherence Methods Patient compliance Pre-Exposure Prophylaxis - methods Prevention pre‐exposure prophylaxis Prophylaxis psychosocial intervention Quality management Sexually transmitted diseases South Africa sub‐Saharan Africa Teenage girls Young Adult Young women Zimbabwe |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NjtNADB6hPSEhxD-BBYxAICGVTeYnk3AriFV3JbjAor2NJjOT3SJIqm0r4MYj8Dq8Dk-CnUlDKhBcuOXHUVLbY39O48-MPcTFZwP9P6gkdxNpdTYpA-7WgvJFKmuXUb_zq9f57EgeHqvj0agv-iYs0gNHxe0hrJLCOSnSSsiY0DJXhNxioVD7EKv1TG2KqRiDcwy65UBGyvfezy1_irUCDXMfpZ-Opf_3WDxKRmPA2mWc_UvsYg8VYRof8TI7F5or7EJ8zwaxfegq-z5rP4GFj6FZQ1uD9aexfw-W6wVBa1iuNmQQUFsXObmDB6IpHkmvWpgdvINFT-jUNrCIVLBL6MYRwS_mJziZn33Aw42HLxQqoCNxgHmDt6x-fP32xhIHdANxAtEzerj5Z7xjnFVNF0YalGvsaP_l2xezST-OYeIUvSz0msj6KuWod9Vz4fOqKAtlU6vLtM69CJnQmHKFzXhVaelFXeWaGPC1rgLisutsp2mbcJNB6XihlNWFSoNMvSirjPMa0UMovEQMm7AHGyuZRWTdMJFfmRuypelsmbDnZMBBgpiyuwPoP6b3H_Mv_0nYPTK_iW2nw3o3U41AKk9LnifscSdBKx5N5mzfuIA_hbiztiQfbUmeRObwPwnubgniknbbpze-aPqQsjRYGSN4xuqySNj94TRdSZ_JNaFdk0yB5aHSGermRvThQTsCI3GO-DhhTzqn_otizeHBlHdbt_6Him-z8xyhYezg3GU7q7N1uINQblXd7VbtT439RN8 priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ti9QwEA7n-UUQ8d3VU0cUBWHPNkmbVhBZxWPv4PyiK_ctpEm6rpztui9498v8e8403brF4771ZUrazEzmmbbzDGMv0PmMp--DieR2KI2Kh7nH3VJQvIhkaWOqdz7-nI4n8ugkOdlhm_6d7QQuL0ztqJ_UZHG6f_br_D06_LuWQPTNj5nh-5gJZPkVdpVLIcnSj2X3NSHFJTjvqEm35XvBqOHs_39l3gpN2_C1iT8HN9mNFjjCKGj6Ftvx1W12Pbx1g1BMdIf9Gde_wcBPX62hLsG476GaD5brOT0jLFcbaggojQ0M3d4BkRZvSa9qGB9-g3lL71RXMA_EsEtomhPBPx4omM4Wp3i4cnBOCwc0lA4wq3DIYvjFEB90BaEb0Vu6tdkZjhf6VtNlgRLlLpscfPr6cTxsWzMMbUIvDp0i4r4isVTH6rhwaZHlWWIio_KoTJ3wsVAYfoWJeVEo6URZpIrY8JUqPGK0e2y3qiv_gEFueZYkRmVJ5GXkRF7EnJeIJHzmJOLZAXu-0ZGeBwYOHbiWuSZN6kaTA_aB1NdJEGt2c6BeTHXrhBohuhTWShEVQgZwFNvMpwaTztJ5HOopKV-HEtTO9_VIIahKo5ynA_aqkSB7RIVZ0xYx4KMQj1ZP8mVPchpYxC8S3OsJonvb_umNJeqNd2jMkhFIY6aZDdiz7jRdSb_MVb5ek0yGqWKiYpyb-8GCu9kRuCqniJUH7HVj0pdMrD46HPFm6-Hld_KIXeMIAEOd5h7bXS3W_jECtlXxpPHGv1IkPUo priority: 102 providerName: Scholars Portal – databaseName: Wiley Online Library Open Access dbid: 24P link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlZ1bixMxFMfDur4IIt6trhpRFIS6M7lMZsSXKi7dBUXQlX0LuU2t6EzpBfXNj-DX8ev4STwnmc62KIJv7cwJ0-bknPyT9vxCyAMIPhPw90EpmBsKo_JhFeBtzXG-yETtcqx3fvW6GB-LoxN5skOerWthEh-i33DDyIj5GgPc2MX-KTT049SwJ6D_y-oMOQu6psQxzcSbdR4uIPFWsRxSwlgoJOvhpGz_tO3WdBSp_X_m5o3JaVPAxhno4CK50ElHOkq-vkR2QnOZnE_7bjSVE10hP8ftF2ro59CsaFtT4z-kej66WM1QatPFcg2HoLVxidEdPEVs8Yb1sqXjw_d01gGe2obOEhp2QePxRPSUBEUn0_knuNx4-g1TB41QBzpt4JH21_cfbw0yoRuaTiR6ih9u-hWemM6uxoYJi3KVHB-8fPdiPOyOZxg6iZuHXiG8z0qHtayecV_YsiqlyYyqsrrwPORcwRTMTc6sVcLz2hYKifhK2QA67RrZbdom3CC0cqyU0qhSZkFknlc2Z6wGNRFKL0DTDsj9tZf0LFE4dOItM42-1NGXA_IcHdhbIDk7XmjnE90FogaZLrhzgmeWiySQcleGwsDCs_YBHnUX3a9TGWof_3qkQFgVWcWKAXkULTADgMuc6QoZ4KsgS2vL8uGW5SSRxP9muLdlCCHutm-vx6LuUsxCw0oZxDSsNssBudffxpb4t7kmtCu0KWG5KFUOfXM9jeG-dzhk5gL08oA8joP6Hx2rjw5HLL66-T_Gt8g5BpIwVW7ukd3lfBVug4Rb2jsxUn8DANM_mA priority: 102 providerName: Wiley-Blackwell |
Title | How a menu of adherence support strategies facilitated high adherence to HIV prevention products among adolescent girls and young women in sub‐Saharan Africa: a mixed methods analysis |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjia2.26189 https://www.ncbi.nlm.nih.gov/pubmed/37936551 https://www.proquest.com/docview/2894167538 https://www.proquest.com/docview/2887475719 https://doaj.org/article/81b43cc430b340078221c8e6a899fde0 |
Volume | 26 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZY-4KEuF8KoxiBQEJKl9hJnPCCurGpm7QxAa2qvViO7ZRySUov4vLH-HucE6ddC2gPvKRtciI77vHnz47Pdwh5Cp1PWXw_GIVMe6ESgZda-JlzHC_8MNcBxjsfn8S9fng0jIb1gtus3la5xMQKqE2pcY18ByYGwB2AXCevJl89zBqFb1frFBpbpMkTmOk0SHPvzeDw9RKLYwDfdCVKynY-jhXrwJwBk7qvDUOVWv_fmLw2KK0T12rkObhG5LLObsPJp85innX0zz_kHP__oa6TqzUppV3nRTfIJVvcJFfcih51gUq3yK9e-Y0q-sUWC1rmVJkPLlKQzhYTJPF0Nl_KTtBcaaf-bQ1FQeQ163lJe4cDOqmlo8qCTpzo7IxWiY_oucYUHY2nn-F0YegPBCVayUXQcQFFZt47hVrTBXWZjl5i1cbfoTyXExtvc3Irt0n_YP_9Xs-r0z54OsJFSSNQFDCLNMbIGsZNnCVpEilfidTPY8NtwAUM7VwFLMtEaHiexQKV9oXILPC_O6RRlIW9R2iqWRJFSiSRb0Pf8DQLGMuBpdjEhMCVW-TJ0gvkxKl7SKfjzCT6iqx8pUV20UFWFqjIXZ0opyNZd3AJ9D_kWofcz3joiFegExsrmNDmxkJRj9C9pAtvXeGK7AogbLGfsrhFnlcWiCzwh2lVB0jAo6BG14blsw3LkVMo_5fh9oYhQIfevLx0S1lD10ye-2SLPF5dxjtxO15hywXaJDANjUQAbXPX9ZFV63BA_Bh4eIu8qDrNBQ0rjw67rPp2_-KaPCCXGZBLFwO6TRrz6cI-BDI4z9pki4WncBRD0SbN7qB_1ofP3f2T07ftGg3a1UILHI_D5Dd3EWal |
link.rule.ids | 315,786,790,870,2115,2236,11589,12083,21416,24346,27955,27956,31752,31753,33777,33778,38549,43343,43838,43928,46085,46509,50847,50956,74100,74657,74767 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLagewAJcb8UBjMCgTQpXWInccILGoOpHdt4YJv2ZvmWUi5J6UVc_hh_j3PipGsB7YG3NjlRHOf4O58dn-8Q8hQGn3L4fTCJmQliJaIgd_C34BgvwrgwEeY7Hxym_eN47zQ5bRbcps22yhYTa6C2lcE18i2YGAB3AHKdvRx_DbBqFH5dbUpoXCRrEFhZ1iFrO-9OBq9bLE4BfPOFKCnb-jhSrAdzBizqvhSGarX-vzF5KSgtE9c68uxeI7Jts99w8qk3n-me-fmHnOP_P9R1crUhpXTbe9ENcsGVN8kVv6JHfaLSLfKrX32jin5x5ZxWBVX2g88UpNP5GEk8nc5a2QlaKOPVv52lKIi8ZD2raH9wQseNdFRV0rEXnZ3SuvARPdOYosPR5DMcLi39gaBEa7kIOirhljp4r1BruqS-0tELbNroO9zP18TGy7zcym1yvPvmaKcfNGUfApPgoqQVKAqoE4M5spZxm-oszxIVKpGHRWq5i7iA0M5VxLQWseWFTgUq7QuhHfC_O6RTVqW7R2huWJYkSmRJ6OLQ8lxHjBXAUlxmY-DKXfKk9QI59uoe0us4M4m-Imtf6ZJX6CALC1Tkrg9Uk6FsBrgE-h9zY2Ieah574hWZzKUKJrSFdXCrDXQv6dNbF7gitwUQtjTMWdolz2sLRBZ4YUY1CRLwKKjRtWL5bMVy6BXK_2W4vmII0GFWT7duKRvomsozn-ySx4vTeCVuxytdNUebDKahiYigb-76MbLoHQ6InwIP75LNetCc07Fyb7DN6l_3z2_JBrnUPzrYl_uDw7cPyGUGRNPng66Tzmwydw-BGM70o2b0_waPRWKn |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ti9QwEA56gggivrt6ehFFQajbJm3T-kXWl2X31EPQO_ZbSJN0XdG2bndRf5l_z5mk29tFuW99mZI2k5l5kmaeIeQxGJ-y-H8wiZkOYiWiILdwWnKMF2Fc6gjznT8cpZPj-HCWzLr9T223rXLjE52jNrXGNfIhTAwAOwC4zoZlty3i45vxy-ZHgBWk8E9rV07jPLkAUTLEMg5i1k--UnDDeU9PyoZfF4o9h9kDlnffCkiOt_9f77wVnrYhrItB46vkSgce6chr-xo5Z6vr5LJfeaM-oegG-TOpf1JFv9tqTeuSKvPFZ_TRdt0g2KbtakMPQUulPUu3NRSJi7ekVzWdTE9o01E81RVtPDlsS12BInrKBUXni-U3uFwZ-hudB3W0DnRRQZNF8EkhJ3RFfUWiF_hqi1_Qnq9djY95WpSb5Hj89vPrSdCVZwh0gouHRiB5X5FozGU1jJu0yPIsUaESeVimhtuICwjBXEWsKERseFmkAhnxhSgs4LRbZK-qK3uH0FyzLEmUyJLQxqHheRExVgKasJmJAdMOyKONjmTjWTik51tmEjUpnSYH5BWqr5dA5mx3oV7OZWeIEmB6zLWOeVjw2AOkSGc2VTDxLI2Fpg5Q-dKnofb2L0cCgFUa5iwdkKdOAj0AKEyrLpEBPgW5tHYkn-xIzj2T-P8E93cEwcT17u3NSJSdi2nlqUEMyMP-Nj6J2-YqW69RJoPpYiIi6JvbfgT3vcPBM6eAlwfkmRvSZ3SsPJyOmDu6e_abHJCLYJTy_fTo3T1yiQEe9Gmb-2RvtVzb-4DfVsUDZ5h_AeI_Qnc |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=How+a+menu+of+adherence+support+strategies+facilitated+high+adherence+to+HIV+prevention+products+among+adolescent+girls+and+young+women+in+sub-Saharan+Africa%3A+a+mixed+methods+analysis&rft.jtitle=Journal+of+the+International+AIDS+Society&rft.au=Roberts%2C+Sarah+T&rft.au=Mancuso%2C+Noah&rft.au=Williams%2C+Kristin&rft.au=Nabunya%2C+Hadijah+Kalule&rft.date=2023-11-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.eissn=1758-2652&rft.volume=26&rft.issue=11&rft_id=info:doi/10.1002%2Fjia2.26189&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1758-2652&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1758-2652&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1758-2652&client=summon |